In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance.
AUTOR(ES)
Watts, J L
RESUMO
The in vitro activity of premafloxacin against 673 veterinary pathogens was evaluated. Premafloxacin was equivalent to ciprofloxacin, enrofloxacin, and danofloxacin in activity against the gram-negative bacilli but was much more active (MIC for 90% of the strains tested [MIC90], 0.015 to 0.25 microg/ml) than the comparison antimicrobial agents (MIC90, 0.13 to 16.0 microg/ml) against the staphylococci, streptococci, and anaerobes tested.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=163880Documentos Relacionados
- In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
- In Vivo Activity of HSR-903, a New Fluoroquinolone, against Respiratory Pathogens
- In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases.
- In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against Mycoplasmas
- Extended-spectrum beta-lactamases.